Regarding the molecular analysis of just the 22 most relevant pancreatic cancer genes, known pathogenic and/or putative driver mutations were identified in the KRAS, TP53, CDKN2A, ATM, and PIK3CA. This evidence concerns the gene CDKN2A and pancreatic neoplasm.